S&P 500   3,001.81 (+0.52%)
DOW   26,804.48 (+0.13%)
QQQ   193.01 (+0.68%)
AAPL   240.24 (+1.62%)
FB   188.53 (+1.44%)
MSFT   137.88 (+0.34%)
GOOGL   1,243.59 (-0.07%)
AMZN   1,773.57 (+0.91%)
CGC   19.87 (-1.68%)
NVDA   195.50 (+2.63%)
MU   44.93 (+3.34%)
BABA   171.91 (+1.64%)
GE   8.88 (-0.89%)
TSLA   255.64 (-0.51%)
AMD   32.14 (+3.78%)
T   38.46 (-0.05%)
F   9.14 (-1.62%)
ACB   3.57 (-2.99%)
NFLX   274.75 (-0.20%)
BAC   30.99 (+2.08%)
S&P 500   3,001.81 (+0.52%)
DOW   26,804.48 (+0.13%)
QQQ   193.01 (+0.68%)
AAPL   240.24 (+1.62%)
FB   188.53 (+1.44%)
MSFT   137.88 (+0.34%)
GOOGL   1,243.59 (-0.07%)
AMZN   1,773.57 (+0.91%)
CGC   19.87 (-1.68%)
NVDA   195.50 (+2.63%)
MU   44.93 (+3.34%)
BABA   171.91 (+1.64%)
GE   8.88 (-0.89%)
TSLA   255.64 (-0.51%)
AMD   32.14 (+3.78%)
T   38.46 (-0.05%)
F   9.14 (-1.62%)
ACB   3.57 (-2.99%)
NFLX   274.75 (-0.20%)
BAC   30.99 (+2.08%)
Log in

Bellus Health Price Target & Analyst Ratings (NYSE:BLU)

$7.05
-0.16 (-2.22 %)
(As of 10/21/2019 11:08 AM ET)
Today's Range
$7.05
Now: $7.05
$7.08
50-Day Range N/A
52-Week Range
$1.76
Now: $7.05
$9.36
Volume1,309 shs
Average Volume38,591 shs
Market Capitalization$390.42 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Bellus Health (NYSE:BLU) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Bellus Health in the last 12 months. Their average twelve-month price target is $16.00, suggesting that the stock has a possible upside of 126.95%. The high price target for BLU is $20.00 and the low price target for BLU is $12.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.00N/AN/AN/A
Price Target Upside: 126.95% upsideN/AN/AN/A

Bellus Health (NYSE:BLU) Consensus Price Target History

Bellus Health (NYSE:BLU) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/30/2019JBL AdvisorsInitiated CoverageBuyMedium
9/30/2019CowenInitiated CoverageOutperformHigh
9/30/2019GuggenheimInitiated CoverageBuy$12.00High
9/30/2019Jefferies Financial GroupInitiated CoverageBuy$20.00High
9/6/2019Bloom BurtonReiterated RatingBuyLow
(Data available from 10/21/2017 forward)
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Cost of Capital Explained

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel